Type
1.
Das. Health in Bihar -- an overview. Health for the millions. 1999;25(4):21-3.
Type
1.
MAKIROV. [Some problems of morbidity due to leprosy in India]. Zdravookhranenie Kazakhstana. 1961;21(12):46-50.
Type
1.
Salako. Drug supply in Nigeria. Journal of clinical epidemiology. 1991;44 Suppl 2:15S-19S.
Type
1.
Mattoo, Handa, Kaur, Gupta, Malhotra. Psychiatric morbidity in vitiligo: prevalence and correlates in India. Journal of the European Academy of Dermatology and Venereology : JEADV. 2002;16(6):573-8.
Type
1.
Hodes, Kloos. Health and medical care in Ethiopia. The New England journal of medicine. 1988;319(14):918-24.
Type
1.
Frommel, Tekle-Haimanot, Verdier, Negesse, Bulto, Denis. HIV infection and leprosy: a four-year survey in Ethiopia. Lancet (London, England). 1994;344(8916):165-6.
Type
1.
Courtright, Hu, Li, Lewallen. Multidrug therapy and eye disease in leprosy: a cross-sectional study in the People’s Republic of China. International journal of epidemiology. 1994;23(4):835-42.
Type
1.
Feitosa, Borecki, Krieger, Beiguelman, Rao. The genetic epidemiology of leprosy in a Brazilian population. American journal of human genetics. 1995;56(5):1179-85.
Type
1.
Andrade, Militao de Albuquerque, Chagastelles Sabroza. The importance of operational factors for the interpretation of indicators in the Hansen’s disease endemic in Brazil. Acta leprologica. 1997;10(3):131-9.
Type
Year of Publication
2014
Secondary Title
The Guardian
Number of Pages
2
Type of Work
Blog post
Publication Language
eng
Citation Key
24667